
Ross Carl Klingsberg MD
Critical Care Medicine, Cystic Fibrosis, Pleural Disease
Associate Professor, Medicine, Tulane University Sch of Med
Join to View Full Profile
1415 Tulane AveNew Orleans, LA 70112
Dr. Klingsberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Tulane UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008
- Tulane UniversityResidency, Internal Medicine, 2002 - 2005
- University of Pennsylvania Health SystemInternship, Internal Medicine, 2002 - 2003
- Tulane University School of MedicineClass of 2002
Certifications & Licensure
- LA State Medical License 2003 - 2025
- MS State Medical License 2019 - 2025
- PA State Medical License 2002 - 2003
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Clinical Trials
- Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF Start of enrollment: 2023 Apr 20
Roles: Contact
Publications & Presentations
PubMed
- 19 citationsTezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse events.Carsten Schwarz, Sivagurunathan Sutharsan, Ralph Epaud, Ross C. Klingsberg, Rainald Fischer
Journal of Cystic Fibrosis. 2021-03-01 - CFTR modulator therapy improves cystic fibrosis-related diabetes. But how?Christine M. Bojanowski, Sarah M. Wilson, Ross C. Klingsberg
Journal of Diabetes and Its Complications. 2021-02-25 - 26 citationsLong-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR ...Patrick A. Flume, Reta Fischer Biner, Damian G Downey, Cynthia A. Brown, Manu Jain
The Lancet. Respiratory Medicine. 2021-02-10
Press Mentions
- New Cystic Fibrosis Medicine Changing Lives After Testing in New OrleansDecember 3rd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: